Bridging the gap between traditional entry strategies

Our value proposition offers a novel solution that bridges the gap between traditional go-it-alone and out-licensing strategies by providing a low risk shared-value approach. It may also be called a “go-it-alone – with us” strategy.

We offer research-driven pharmaceutical, biotech and medical devices companies a platform of excellence from which we build a dedicated European commercial organization. We leverage our unmatched launch expertise and lead the product to a sustained, successful European commercialization.

European operations built from a platform of excellence

Cutting through the complexities of European markets

Europe is a highly attractive pharmaceutical arena with a total population of over 500 million and annual expenditures of $145 billion. This market is second only to North America but it is highly complex – we know how to navigate it and maximize the opportunities for success.

Entrust the European success of your innovative therapy

We have unmatched senior executive experience and access to an unparalleled network of European experts. We help build our clients’ reputation in Europe – we work together to make your first product launch in Europe a sustained success.